Windtree Therapeutics Appoints Mark Strobeck, Ph.D. to Board of Directors
WARRINGTON, Pa. , June 27, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that the Company appointed Mark Strobeck , Ph.D.
Article Date
June 27, 2023
This article is featured on another website.
Go to article
August 4, 2026
HIRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina
Find HiRO at SCDM 2026 at Booth #526 HiRO is excited to announce our attendance…
August 4, 2026
HIRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina
Find HiRO at SCDM 2026 at Booth #526 HiRO is excited to announce our attendance…
June 1, 2026
Chime Biologics and Daewoong Pharmaceutical Enter Strategic Partnership to Advance Dupilumab Biosimilar Development and Commercialization in Global Markets
June 1, 2026